Finding the breakthrough compounds hiding in chemical space
Download the guide and learn what generative chemistry is, where it fits in the discovery workflow, and best practices to avoid common pitfalls.
Summary
This article explores the psychological barriers and risks of cognitive biases to R&D decision-making. It contrasts current practice with the use of evidence-based medicine by healthcare practitioners. It touches on how computational tools, such as StarDrop‘s integrated suite of discovery software, can help support good decision making in drug discovery.
Citation details
A. T. Chadwick and M. D. Segall, Drug Discovery Today, 2010, 15 (13/14), pp. 561-569.
DOI: 10.1016/j.drudis.2010.05.007
Find out more
For more information on how to use computational tools to support good discovery decisions, explore our StarDrop webpage.
More resources
How can I predict binding affinity without a target protein structure?
Why traditional ligand-based QSAR methods have fallen short You might be sceptical about ligand-based QSAR approaches; many researchers are. We discussed why there has…
Ensemble-based conformational modelling for macrocycles
From X-ray refinement to lead optimisation Conventional ligand-fitting and refinement methods in X-ray electron density maps often yield models with…
